Ethic Inc. Novartis Ag Transaction History

Ethic Inc.

$4.8 Billion
Q1 2025

A detailed history of Ethic Inc. transactions in Novartis Ag stock. As of the latest transaction made, Ethic Inc. holds 85,921 shares of NVS stock, worth $10.6 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

85,921

Previous 119,673 28.2%

Holding current value

$10.6 Million

Previous $11.6 Million 17.75%

% of portfolio

0.2%

Previous 0.24%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$97.14 - $115.57 $3.28 Million - $3.9 Million	-33,752 Reduced 28.2%	85,921 $9.58 Million
Q4 2024 Feb 14, 2025	SELL	$96.78 - $117.18 $1.27 Million - $1.53 Million	-13,074 Reduced 9.85%	119,673 $11.6 Million
Q3 2024 Nov 13, 2024	SELL	$106.13 - $120.89 $871,327 - $992,506	-8,210 Reduced 5.82%	132,747 $15.3 Million
Q2 2024 Aug 13, 2024	BUY	$92.57 - $107.37 $759,999 - $881,507	8,210 Added 6.18%	140,957 $15 Million
Q1 2024 May 13, 2024	BUY	$95.27 - $108.47 $760,921 - $866,349	7,987 Added 6.4%	132,747 $12.8 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $1.09 Million - $1.2 Million	11,780 Added 10.43%	124,760 $12.6 Million
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $1.28 Million - $1.42 Million	13,489 Added 13.56%	112,980 $11.5 Million
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $149,142 - $169,114	-1,612 Reduced 1.59%	99,491 $10 Million
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $215,360 - $249,751	-2,691 Reduced 2.59%	101,103 $9.3 Million
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $2.53 Million - $3.1 Million	33,521 Added 47.7%	103,794 $9.42 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $866,371 - $1.01 Million	-11,612 Reduced 14.18%	70,273 $5.34 Million
Q2 2022 Aug 10, 2022	BUY	$80.52 - $93.75 $370,230 - $431,062	4,598 Added 5.95%	81,885 $6.92 Million
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $2.96 Million - $3.35 Million	37,008 Added 91.88%	77,287 $6.78 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $284,050 - $314,095	3,564 Added 9.71%	40,279 $3.52 Million
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $1.05 Million - $1.22 Million	12,850 Added 53.84%	36,715 $3 Million
Q2 2021 Aug 10, 2021	BUY	$85.24 - $94.15 $1.08 Million - $1.19 Million	12,675 Added 113.27%	23,865 $2.18 Million
Q1 2021 May 13, 2021	BUY	$83.5 - $98.47 $180,527 - $212,892	2,162 Added 23.95%	11,190 $957,000
Q4 2020 Feb 10, 2021	BUY	$78.07 - $94.43 $303,692 - $367,332	3,890 Added 75.71%	9,028 $853,000
Q3 2020 Oct 27, 2020	SELL	$82.14 - $91.0 $18,152 - $20,111	-221 Reduced 4.12%	5,138 $447,000
Q2 2020 Aug 12, 2020	BUY	$80.93 - $91.1 $207,585 - $233,671	2,565 Added 91.8%	5,359 $468,000
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $197,451 - $276,633	2,794 New	2,794 $230,000

Others Institutions Holding NVS

# of Institutions

1,521

Shares Held

142M

Call Options Held

1.63M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $265B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.

Account